Cover Image
Market Research Report
Product code 
1077383

Nucleic Acid Based Gene Therapy Global Market Report 2022

Published: Pre-Order | The Business Research Company | 200 Pages | Delivery time: 2-10 business days

Price

Back to Top
Nucleic Acid Based Gene Therapy Global Market Report 2022
Published: Pre-Order
The Business Research Company
Content info: 200 Pages
Delivery time: 2-10 business days
  • Description
  • Table of Contents

“Nucleic Acid Based Gene Therapy Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global nucleic acid based gene therapy market.

This report focuses on nucleic acid based gene therapy market which is experiencing strong growth. The report gives a guide to the nucleic acid based gene therapy market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the nucleic acid based gene therapy market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Nucleic Acid Based Gene Therapy Market market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider nucleic acid based gene therapy market market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The nucleic acid based gene therapy market market section of the report gives context. It compares the nucleic acid based gene therapy market market with other segments of the nucleic acid based gene therapy market market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, nucleic acid based gene therapy market indicators comparison.

Scope

Markets Covered:

  • 1) By Technology: Anti-Sence and Anti-Gene; Short Inhibitory Sequences; Gene Transfer Therapy; Nucleoside Analogs; Ribozymes; Aptamers; Other Technologies
  • 2) By Application: Oncology; Muscular Dystrophy/ Muscular Disorders; Rare Diseases
  • 3) By End User: Hospitals And Clinics; Academic And Research Institutes
  • Companies Mentioned: Celsion Corporation; Wave Life Sciences; Imugene; Caperna; Phylogica
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Product Code: r1308

Table of Contents

1. Executive Summary

2. Nucleic Acid Based Gene Therapy Market Characteristics

3. Nucleic Acid Based Gene Therapy Market Trends And Strategies

4. Impact Of COVID-19 On Nucleic Acid Based Gene Therapy

5. Nucleic Acid Based Gene Therapy Market Size And Growth

  • 5.1. Global Nucleic Acid Based Gene Therapy Historic Market, 2016-2021, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Nucleic Acid Based Gene Therapy Forecast Market, 2021-2026F, 2031F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Nucleic Acid Based Gene Therapy Market Segmentation

  • 6.1. Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Anti-Sence and Anti-Gene
  • Short Inhibitory Sequences
  • Gene Transfer Therapy
  • Nucleoside Analogs
  • Ribozymes
  • Aptamers
  • Other Technologies
  • 6.2. Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Oncology
  • Muscular Dystrophy/ Muscular Disorders
  • Rare Diseases
  • 6.3. Global Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospitals And Clinics
  • Academic And Research Institutes

7. Nucleic Acid Based Gene Therapy Market Regional And Country Analysis

  • 7.1. Global Nucleic Acid Based Gene Therapy Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 7.2. Global Nucleic Acid Based Gene Therapy Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Nucleic Acid Based Gene Therapy Market

  • 8.1. Asia-Pacific Nucleic Acid Based Gene Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Nucleic Acid Based Gene Therapy Market

  • 9.1. China Nucleic Acid Based Gene Therapy Market Overview
  • 9.2. China Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Nucleic Acid Based Gene Therapy Market

  • 10.1. India Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Nucleic Acid Based Gene Therapy Market

  • 11.1. Japan Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Nucleic Acid Based Gene Therapy Market

  • 12.1. Australia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Nucleic Acid Based Gene Therapy Market

  • 13.1. Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Nucleic Acid Based Gene Therapy Market

  • 14.1. South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Nucleic Acid Based Gene Therapy Market

  • 15.1. Western Europe Nucleic Acid Based Gene Therapy Market Overview
  • 15.2. Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Nucleic Acid Based Gene Therapy Market

  • 16.1. UK Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Nucleic Acid Based Gene Therapy Market

  • 17.1. Germany Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Nucleic Acid Based Gene Therapy Market

  • 18.3. France Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Nucleic Acid Based Gene Therapy Market

  • 19.1. Eastern Europe Nucleic Acid Based Gene Therapy Market Overview
  • 19.2. Eastern Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Nucleic Acid Based Gene Therapy Market

  • 20.1. Russia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Nucleic Acid Based Gene Therapy Market

  • 21.1. North America Nucleic Acid Based Gene Therapy Market Overview
  • 21.2. North America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Nucleic Acid Based Gene Therapy Market

  • 22.1. USA Nucleic Acid Based Gene Therapy Market Overview
  • 22.2. USA Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Nucleic Acid Based Gene Therapy Market

  • 23.1. South America Nucleic Acid Based Gene Therapy Market Overview
  • 23.2. South America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Nucleic Acid Based Gene Therapy Market

  • 24.1. Brazil Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Nucleic Acid Based Gene Therapy Market

  • 25.1. Middle East Nucleic Acid Based Gene Therapy Market Overview
  • 25.2. Middle East Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Nucleic Acid Based Gene Therapy Market

  • 26.1. Africa Nucleic Acid Based Gene Therapy Market Overview
  • 26.2. Africa Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Nucleic Acid Based Gene Therapy Market Competitive Landscape And Company Profiles

  • 27.1. Nucleic Acid Based Gene Therapy Market Competitive Landscape
  • 27.2. Nucleic Acid Based Gene Therapy Market Company Profiles
    • 27.2.1. Celsion Corporation
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Wave Life Sciences
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Imugene
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Caperna
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Phylogica
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Nucleic Acid Based Gene Therapy Pipeline Analysis

29. Key Mergers And Acquisitions In The Nucleic Acid Based Gene Therapy Market

30. Nucleic Acid Based Gene Therapy Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer